Hester Biosciences informs about outcome of board meeting

04 Mar 2020 Evaluate

This is in reference to letter  dated  29  February  2020  intimating  the  date  of  the  Board  Meeting  for consideration of Appointment of Chief Financial Officer (CFO) of the Company. Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has informed that Board of Directors, in their Meeting held today, have approved the Appointment of Sahil Shah as a Chief  Financial Officer (KMP) the  Company with effect  from  01 March  2020.  The details required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as enclosed. The company has attached Press Release issued in this regard.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1649.00 17.95 (1.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×